Impax Asset Management Group plc lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 24.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 98,895 shares of the company’s stock after selling 31,472 shares during the period. Impax Asset Management Group plc’s holdings in Colgate-Palmolive were worth $8,438,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently modified their holdings of CL. State Street Corp boosted its holdings in Colgate-Palmolive by 97.4% in the 2nd quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after buying an additional 46,476,510 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Colgate-Palmolive by 8.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock worth $1,240,652,000 after buying an additional 1,010,872 shares in the last quarter. First Eagle Investment Management LLC increased its stake in Colgate-Palmolive by 1.1% during the 2nd quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock worth $752,298,000 after buying an additional 88,917 shares in the last quarter. Amundi raised its holdings in shares of Colgate-Palmolive by 19.9% during the second quarter. Amundi now owns 6,218,257 shares of the company’s stock valued at $570,090,000 after acquiring an additional 1,033,918 shares during the last quarter. Finally, Bank of America Corp DE acquired a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $567,483,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Insider Buying and Selling
In related news, insider John Hazlin sold 23,376 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,317,730.40. Following the transaction, the insider owned 27,021 shares in the company, valued at approximately $2,679,132.15. This trade represents a 46.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Noel R. Wallace sold 20,000 shares of the business’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $100.26, for a total value of $2,005,200.00. Following the transaction, the chief executive officer directly owned 359,700 shares in the company, valued at $36,063,522. This trade represents a 5.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 77,414 shares of company stock valued at $7,613,786 over the last ninety days. 0.43% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on CL shares. Royal Bank Of Canada raised their target price on Colgate-Palmolive from $104.00 to $105.00 and gave the company an “outperform” rating in a research report on Monday, November 2nd. Wells Fargo & Company boosted their price target on Colgate-Palmolive from $90.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Monday, November 2nd. Jefferies Financial Group reissued a “hold” rating and issued a $89.00 price objective (up from $88.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Weiss Ratings downgraded Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Finally, BNP Paribas Exane restated an “outperform” rating and issued a $108.00 price objective (up from $97.00) on shares of Colgate-Palmolive in a report on Monday, November 2nd. Thirteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.22.
Check Out Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Stock Down 0.9%
Shares of NYSE CL opened at $98.76 on Thursday. Colgate-Palmolive Company has a 12-month low of $75.96 and a 12-month high of $101.81. The stock has a market cap of $78.51 billion, a PE ratio of 38.73, a P/E/G ratio of 4.51 and a beta of 0.31. The company has a current ratio of 0.96, a quick ratio of 0.63 and a debt-to-equity ratio of 11.23. The company has a 50-day moving average of $91.62 and a 200 day moving average of $90.48.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. During the same quarter in the prior year, the firm earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, sell-side analysts predict that Colgate-Palmolive Company will post 3.92 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th were given a $0.53 dividend. The ex-dividend date was Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. Colgate-Palmolive’s dividend payout ratio is 83.14%.
Colgate-Palmolive Company Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
